A detailed history of Jpmorgan Chase & CO transactions in Exscientia PLC stock. As of the latest transaction made, Jpmorgan Chase & CO holds 6,042 shares of EXAI stock, worth $30,270. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,042
Previous 10,584 42.91%
Holding current value
$30,270
Previous $60,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$3.99 - $6.04 $18,122 - $27,433
-4,542 Reduced 42.91%
6,042 $30,000
Q1 2024

May 10, 2024

SELL
$5.3 - $7.51 $441,299 - $625,312
-83,264 Reduced 88.72%
10,584 $60,000
Q4 2023

Feb 12, 2024

SELL
$4.35 - $6.88 $157,317 - $248,815
-36,165 Reduced 27.82%
93,848 $601,000
Q3 2023

Nov 14, 2023

BUY
$4.52 - $8.9 $581,290 - $1.14 Million
128,604 Added 9127.32%
130,013 $587,000
Q2 2023

Aug 11, 2023

BUY
$4.79 - $8.3 $6,289 - $10,897
1,313 Added 1367.71%
1,409 $8,000
Q1 2023

May 11, 2023

BUY
$5.3 - $10.93 $508 - $1,049
96 New
96 $0

Others Institutions Holding EXAI

About Exscientia plc


  • Ticker EXAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 122,461,000
  • Market Cap $614M
  • Description
  • Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on s...
More about EXAI
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.